Research

Calcium

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Colorectal cancer

Source: Cancer Epidemiol Biomarkers Prev, January 2005;14(1):126-32.

Research: Researchers investigated the association between calcium intake and colorectal cancer in a prospective cohort of 45,354 women without a history of colorectal cancer, who successfully completed a 62-item National Cancer Institute/Block food-frequency questionnaire. Women were followed for an average of 8.5 years, during which time 482 subjects developed colorectal cancer. Study investigators created categories for calcium from supplements as follows: 0 mg/day (n = 25,441), 0 to 400 mg/day (n = 9452), 401 to 800 mg/day (n = 4176) and >800 mg/day (n =6285).

Results: High consumption of calcium from diet and calcium from supplements resulted in even further risk reduction compared with low consumption of both sources of calcium. These data indicate that a difference of 800 mg of calcium per day was associated with an approximately 25% reduction in risk of colorectal cancer, and this reduction in risk occurred regardless of the source of the calcium (i.e., diet or supplements).

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters